Results 191 to 200 of about 117,037 (362)

Proton Pump Inhibitor Use and Incident Hypertension in Menopausal Women. [PDF]

J Am Heart Assoc
Soliman AI, Wactawski-Wende J, Millen AE, Gray SL, Eaton CB, Hovey KM, Donneyong M, Saquib N, Mouton CP, Laddu D, Liu S, Shimbo D, Wassertheil-Smoller S, LaMonte MJ.   +13 more
europepmc   +1 more source

A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole [PDF]

, 2001
M. J. R. Janssen, Arnoud H A M van Oijen, André L. M. Verbeek, Jan B.�M.�J. Jansen, W. A. De Boer   +4 more
openalex   +1 more source

High Oxidation State V‐O‐Co Structure Promotes the Role of V‐*O Intermediates in Efficient HMF Oxidation

Advanced Science, EarlyView.
By designing a high oxidation state VH‐O‐CoH structure, the V‐*O intermediate can be effectively generated, thereby facilitating the catalytic oxidation of HMF. This innovative design strategy demonstrates broad applicability, as it not only enables the formation of the active intermediate in various materials (V‐Ni2P), but also facilitates its ...
Honglei Wang, Xue Wen, Jiuxiang Dai, Dawei Xu, Xianzhu Luo, Pan Luo, Hongshuai Cao   +6 more
wiley   +1 more source

Safety of Proton Pump Inhibitor in Paediatrics: A Study Based on EudraVigilance Data. [PDF]

Fundam Clin Pharmacol
Santi Laurini G, Nikitina V, Montanaro N, Motola D.   +3 more
europepmc   +1 more source

High dose proton pump inhibitor response as an initial strategy for a clinical diagnosis of gastro-oesophageal reflux disease (GERD)

, 2000
J Brun, Heléne Sörngård
openalex   +1 more source

Problems Associated with the Clinical Use of Proton Pump Inhibitors [PDF]

, 2001
Derek Gillen, Kenneth E.L. McColl
openalex   +1 more source

Serine Grafted Silica Coated Nanoscale Zero‐Valent Iron with Enhanced Fenton‐Like Degradation of Mixed Organic Solvents of Tributyl Phosphate and n‐dodecane

Advanced Science, EarlyView.
Serine grafted silica coated nanoscale zero‐valent iron is synthesized. Through the SiO2 coating and serine grafting, the aggregation and oxidation of nZVI are reduced, and the slow release of Fe2+ ensured the catalytic cycle. The adsorption capacity for TBP and n‐dodecane is higher, because of the synergistic effect of surface functional groups.
Peijie Sun, Haifeng Xu, Lejin Xu
wiley   +1 more source

Efficacy and Safety of Clopidogrel With and Without a Proton Pump Inhibitor: A Systematic Review and Meta-Analysis. [PDF]

Basic Clin Pharmacol Toxicol
Axelsson MAB, Parodi López N, Wikström Jonsson E, Wallerstedt SM.   +3 more
europepmc   +1 more source

Esophageal manometry and adequacy of acid suppression with proton pump inhibitors (PPI) in patients with barrett's epithelium (BE)

, 2000
Kumar Basu, Rob Bale, Barbara Pick, John de Caestecker   +3 more
openalex   +1 more source

ARL3 Enhances ERα Stability via USP10 Deubiquitination to Promote Endocrine Resistance and Drive Mitochondrial Metabolic Reprogramming in HR+ Breast Cancer

Advanced Science, EarlyView.
This study identifies ADP‐ribosylation factor‐like protein 3 (ARL3) as a novel chaperone that stabilizes estrogen receptor α (ERα) in breast cancer. ARL3 promotes tumor growth by recruiting USP10 to remove ubiquitin chains from ERα, preventing its degradation.
Han Li, Yang Liu, Zehao Cai, Kang Li, Shun Gao, Ailin Lan, Dan Shu, Kuan He, Xin Liu, Yang Peng, Shipeng Guo, Haochen Yu, Aishun Jin, Meiying Shen, Shengchun Liu   +14 more
wiley   +1 more source